Back to Search
Start Over
Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table 1. Clinical characteristics of patients with relapsed or refractory acute myeloid leukemia.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....17af767489f40f6d373f02d12a3e280f